LINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer

12 July 2022: Database Analysis

Aimin Chang ^ACDEFG* , Ying Shi ^BCDE , Ping Wang ^BCD , Jingjing Ren ^BCF

DOI: 10.12659/MSM.935070

Med Sci Monit 2022; 28:e935070

Table 2 LINC00963 expression associated with clinicopathologic characteristics (logistic regression).

Characteristics	Odds Ratio in LINC00963 expression	Odds ratio (OR)	P value
T stage (T2 & T3 & T4 vs T1)	241	0.66 (0.40–1.11)	0.120
N stage (N1 vs N0)	193	2.36 (1.26–4.52)	0.008
M stage (M1 vs M0)	126	0.46 (0.10–1.74)	0.276
Clinical stage (Stage II & Stage III & Stage IV vs Stage I)	297	0.71 (0.45–1.13)	0.150
Primary therapy outcome (CR vs PD & SD &PR)	217	2.23 (1.08–4.80)	0.033
Histological type (squamous cell carcinoma vs adenosquamous)	304	0.16 (0.07–0.33)
Histologic grade (G3 & G4 vs G1 & G2)	272	1.04 (0.64–1.68)	0.879
PIK3CA status (Mut vs WT)	286	1.28 (0.76–2.14)	0.350